The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines

Journal of Virology

Volumn 84, Issue 6, 2010, Pages 2648-2656

  Borenstein, Ronen ^a   Zeigerman, Haim ^a   Frenkel, Niza ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

RESTRICTION ENDONUCLEASE; VIRUS DNA;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL LINE; CONTROLLED STUDY; EXON; GENE DELETION; GENE SEQUENCE; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6A; MONONUCLEAR CELL; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SEQUENCE ANALYSIS; T LYMPHOCYTE; UMBILICAL CORD BLOOD; VIRUS CULTURE; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN;

BASE SEQUENCE; CELL LINE; EXONS; GENETIC VECTORS; GENOME, VIRAL; HERPESVIRUS 6, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; REPETITIVE SEQUENCES, NUCLEIC ACID; T-LYMPHOCYTES; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); HERPESVIRIDAE; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6A;

EID: 77649120199     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01951-09     Document Type: Article

References (48)

1. Ablashi, D., H. Agut, Z. Berneman, et al. 1993. Human herpesvirus-6 strain groups: a nomenclature. Arch. Virol. 129:363-366.
2. Achour, A., I. Malet, C. Deback, P. Bonnafous, D. Boutolleau, A. Gautheret-Dejean, and H. Agut. 2009. Length variability of telomeric repeat sequences of human herpesvirus 6 DNA. J. Virol. Methods 159:127-130.
3. Borenstein, R., and N. Frenkel. 2009. Cloning human herpes virus 6A genome into bacterial artificial chromosomes and study of DNA replication intermediates. Proc. Natl. Acad. Sci. U. S. A. 106:19138-19143.
4. Borenstein, R., O. Singer, A. Moseri, and N. Frenkel. 2004. Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells. J. Virol. 78:4730-4743.
5. Carrigan, D. R., W. R. Drobyski, S. K. Russler, M. A. Tapper, K. K. Knox, and R. C. Ash. 1991. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 338:147-149.
6. Cermelli, C., R. Berti, S. S. Soldan, M. Mayne, J. M. D'Ambrosia, S. K. Ludwin, and S. Jacobson. 2003. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J. Infect. Dis. 187:1377-1387.
7. Cha, T. A., E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R. Spaete. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
8. De Bolle, L., L. Naesens, and E. De Clercq. 2005. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev. 18: 217-245.
9. Deiss, L. P., J. Chou, and N. Frenkel. 1986. Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus DNA. J. Virol. 59:605-618.
10. Deiss, L. P., and N. Frenkel. 1986. Herpes simplex virus amplicon: cleavage of concatemeric DNA is linked to packaging and involves amplification of the terminally reiterated a sequence. J. Virol. 57:933-941.
11. Di Luca, D., G. Katsafanas, E. C. Schirmer, N. Balachandran, and N. Frenkel. 1990. The replication of viral and cellular DNA in human herpesvirus 6-infected cells. Virology 175:199-210.
12. Downing, R. G., N. Sewankambo, D. Serwadda, R. Honess, D. Crawford, R. Jarrett, and B. E. Griffin. 1987. Isolation of human lymphotropic herpesviruses from Uganda. Lancet ii:390.
13. Drobyski, W. R., W. M. Dunne, E. M. Burd, K. K. Knox, R. C. Ash, M. M. Horowitz, N. Flomenberg, and D. R. Carrigan. 1993. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J. Infect. Dis. 167: 735-739.
14. Fotheringham, J., and S. Jacobson. 2005. Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease. Herpes 12:4-9.
15. Frenkel, N., and E. Roffman. 1995. Human herpesviruses 7, p. 2609-2622. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, PA.
16. Frenkel, N. 2006. The history of the HSV amplicon: from naturally occurring defective genomes to engineered amplicon vectors. Curr. Gene Ther. 6:277-301.
17. Frenkel, N., and R. Borenstein. 2006. Characterization of the lymphotropic Amplicons-6 and Tamplicon-7 vectors derived from HHV-6 and HHV-7. Curr. Gene Ther. 6:399-420.
18. Frenkel, N., E. C. Schirmer, G. Katsafanas, and C. H. June. 1990. T-cell activation is required for efficient replication of human herpesvirus 6. J. Virol. 64:4598-4602.
19. Gompels, U. A., and H. A. Macaulay. 1995. Characterization of human telomeric repeat sequences from human herpesvirus 6 and relationship to replication. J. Gen. Virol. 76:451-458.
20. Gompels, U. A., J. Nicholas, G. Lawrence, M. Jones, B. J. Thomson, M. E. Martin, S. Efstathiou, M. Craxton, and H. A. Macaulay. 1995. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209:29-51.
21. Hall, C. B., C. E. Long, K. C. Schnabel, M. T. Caserta, K. M. McIntyre, M. A. Costanzo, A. Knott, S. Dewhurst, R. A. Insel, and L. G. Epstein. 1994. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl. J. Med. 331:432-438.
22. He, R., Q. Ruan, Y. Qi, Y. P. Ma, Y. J. Huang, Z. R. Sun, and Y. H. Ji. 2006. Sequence variability of human cytomegalovirus UL143 in low-passage clinical isolates. Chin. Med. J. (Engl.) 119:397-402.
23. Kondo, K., H. Nozaki, K. Shimada, and K. Yamanishi. 2003. Detection of a gene cluster that is dispensable for human herpesvirus 6 replication and latency. J. Virol. 77:10719-10724.
24. Lindquester, G. J., and P. E. Pellett. 1991. Properties of the human herpesvirus 6 strain Z29 genome: G + C content, length, and presence of variablelength directly repeated terminal sequence elements. Virology 182:102-110.
25. Locker, H., and N. Frenkel. 1979. BamI, KpnI, and SalI restriction enzyme maps of the DNAs of herpes simplex virus strains Justin and F: occurrence of heterogeneities in defined regions of the viral DNA. J. Virol. 32:429-441.
26. Lopez, C., P. Pellett, J. Stewart, C. Goldsmith, K. Sanderlin, J. Black, D. Warfield, and P. Feorino. 1988. Characteristics of human herpesvirus-6. J. Infect. Dis. 157:1271-1273.
27. Martin, M. E., B. J. Thomson, R. W. Honess, M. A. Craxton, U. A. Gompels, M. Y. Liu, E. Littler, J. R. Arrand, I. Teo, and M. D. Jones. 1991. The genome of human herpesvirus 6: maps of unit-length and concatemeric genomes for nine restriction endonucleases. J. Gen. Virol. 72:157-168.
28. McVoy, M. A., D. E. Nixon, S. P. Adler, and E. S. Mocarski. 1998. Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. J. Virol. 72:48-56.
29. Michel, D., I. Milotic, M. Wagner, B. Vaida, J. Holl, R. Ansorge, and T. Mertens. 2005. The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system. J. Gen. Virol. 86:297-306.
30. Mlechkovich, G., and N. Frenkel. 2007. Human herpesviruses 6A and 6B (HHV-6A and HHV-6B) cause alterations in E2F1/Rb pathways, E2F1 localization, as well as cell cycle arrest in infected T cells. J. Virol. 81:13499-13508.
31. Murphy, E., D. Yu, J. Grimwood, J. Schmutz, M. Dickson, M. A. Jarvis, G. Hahn, J. A. Nelson, R. M. Myers, and T. E. Shenk. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 100:14976-14981.
32. Noble, P. B., J. H. Cutts, and K. K. Carroll. 1968. Ficoll flotation for the separation of blood leukocyte types. Blood 31:66-73.
33. Pietilainen, J., J. O. Virtanen, L. Uotila, O. Salonen, M. Koskiniemi, and M. Farkkila. 2009. HHV-6 infection in multiple sclerosis. A clinical and laboratory analysis. Eur. J. Neurol. [Epub ahead of print.] doi:10.1111/j.1468-1331.2009.0278.x.
34. Rapaport, D., D. Engelhard, G. Tagger, R. Or, and N. Frenkel. 2002. Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl. Infect. Dis. 4:10-16.
35. Salahuddin, S. Z., D. V. Ablashi, P. D. Markham, S. F. Josephs, S. Sturzenegger, M. Kaplan, G. Halligan, P. Biberfeld, F. Wong-Staal, B. Kramarsky, et al. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601.
36. Schirmer, E. C., L. S. Wyatt, K. Yamanishi, W. J. Rodriguez, and N. Frenkel. 1991. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc. Natl. Acad. Sci. U. S. A. 88:5922-5926.
37. Schleimann, M. H., J. M. Moller, E. Kofod-Olsen, and P. Hollsberg. 2009. Direct repeat 6 from human herpesvirus-6B encodes a nuclear protein that forms a complex with the viral DNA processivity factor p41. PLoS One 4:e7457.
38. Severini, A., C. Sevenhuysen, M. Garbutt, and G. A. Tipples. 2003. Structure of replicating intermediates of human herpesvirus type 6. Virology 314:443-450.
39. Smith, S. D., M. Shatsky, P. S. Cohen, R. Warnke, M. P. Link, and B. E. Glader. 1984. Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res. 44:5657-5660.
40. Szostak, J. W., T. L. Orr-Weaver, R. J. Rothstein, and F. W. Stahl. 1983. The double-strand-break repair model for recombination. Cell 33:25-35.
41. Tait, A. R., and S. K. Straus. 2008. Phosphorylation of U24 from human herpes virus type 6 (HHV-6) and its potential role in mimicking myelin basic protein (MBP) in multiple sclerosis. FEBS Lett. 582:2685-2688.
42. Tedder, R. S., M. Briggs, C. H. Cameron, R. Honess, D. Robertson, and H. Whittle. 1987. A novel lymphotropic herpesvirus. Lancet ii:390-392.
43. Thomson, B. J., S. Dewhurst, and D. Gray. 1994. Structure and heterogeneity of the a sequences of human herpesvirus 6 strain variants U1102 and Z29 and identification of human telomeric repeat sequences at the genomic termini. J. Virol. 68:3007-3014.
44. Vlazny, D. A., A. Kwong, and N. Frenkel. 1982. Site-specific cleavage/packaging of herpes simplex virus DNA and the selective maturation of nucleocapsids containing full-length viral DNA. Proc. Natl. Acad. Sci. U. S. A. 79:1423-1427.
45. Wyatt, L. S., N. Balachandran, and N. Frenkel. 1990. Variations in the replication and antigenic properties of human herpesvirus 6 strains. J. Infect. Dis. 162:852-857.
46. Yamanishi, K., Y. Mori, and P. E. Pellett. 2007. Human herpesviruses 6 and 7, p. 2819-2845. In D. M. Knipe and P. M. Howley, Fields virology, 5th ed., vol. 2. Lippincott-Raven, Philadelphia, PA.
47. Yamanishi, K., T. Okuno, K. Shiraki, M. Takahashi, T. Kondo, Y. Asano, and T. Kurata. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i:1065-1067.
48. Yao, K., S. Honarmand, A. Espinosa, N. Akhyani, C. Glaser, and S. Jacobson. 2009. Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis. Ann. Neurol. 65:257-267.